Ionis Pharmaceuticals
(IONS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,984 | -60,644 | -65,478 | -84,801 | -61,251 |
| Depreciation Amortization | 33,070 | 28,680 | 30,507 | 29,126 | 22,554 |
| Accounts receivable | 7,199 | -10,580 | 6,399 | -5,679 | 10,479 |
| Accounts payable and accrued liabilities | 4,824 | 66 | 1,292 | 875 | 1,325 |
| Other Working Capital | 5,059 | 86,025 | 50,207 | -67,395 | -41,436 |
| Other Operating Activity | -4,883 | 19,946 | -21,051 | 15,945 | 4,736 |
| Operating Cash Flow | $6,285 | $63,493 | $1,876 | $-111,929 | $-63,593 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -97,156 | -252,792 | 24,782 | 117,810 | 47,396 |
| PPE Investments | -7,518 | -1,552 | -1,479 | -10,203 | -13,052 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 10,147 |
| Purchase Of Investment | N/A | N/A | -3,790 | -359 | -250 |
| Sale Of Investment | 25,412 | 2,428 | 2,177 | 4,445 | N/A |
| Purchase Sale Intangibles | -3,586 | -3,810 | -3,691 | -3,667 | -4,319 |
| Other Investing Activity | -3,586 | -3,810 | -3,691 | -3,667 | -20,547 |
| Investing Cash Flow | $-82,848 | $-255,726 | $17,999 | $108,026 | $23,694 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 476,448 | N/A | 203,797 | N/A | 4,694 |
| Debt Repayment | 23,071 | -11,039 | -174,137 | -5,864 | -4,354 |
| Common Stock Issued | N/A | 236,250 | 9,470 | 3,567 | 4,356 |
| Other Financing Activity | -439,931 | 2,513 | 0 | 1,625 | 0 |
| Financing Cash Flow | $59,588 | $227,724 | $39,130 | $-672 | $4,696 |
| Beginning Cash Position | 159,973 | 124,482 | 65,477 | 70,052 | 105,255 |
| End Cash Position | 142,998 | 159,973 | 124,482 | 65,477 | 70,052 |
| Net Cash Flow | $-16,975 | $35,491 | $59,005 | $-4,575 | $-35,203 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,285 | 63,493 | 1,876 | -111,929 | -63,593 |
| Capital Expenditure | -7,518 | -1,552 | -1,479 | -10,203 | -13,237 |
| Free Cash Flow | -1,233 | 61,941 | 397 | -122,132 | -76,830 |